Phibro Animal Health PAHC Performance Products — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's performance products — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's performance products — revenue?
- Phibro Animal Health (PAHC) reported performance products — revenue of $18.9M in Q1 2026.
- How has Phibro Animal Health's performance products — revenue changed year-over-year?
- Phibro Animal Health's performance products — revenue decreased by 16.6% year-over-year, from $22.67M to $18.9M.
- What is the long-term trend for Phibro Animal Health's performance products — revenue?
- Over 4 years (2021 to 2025), Phibro Animal Health's performance products — revenue has grown at a 4.6% compound annual growth rate (CAGR), from $67.07M to $80.18M.
- What does performance products — revenue mean?
- This represents the total income generated by the Performance Products segment from its primary business activities, such as the sale of goods and services. It is the primary indicator of the segment's market success and demand for its product portfolio. Consistent revenue growth is a key driver of the segment's long-term value creation.